Literature DB >> 8813916

Long-term predictive role of urodynamics: an 8-year follow-up of prostatic surgery for lower urinary tract symptoms.

K M Jensen1, T B Jørgensen, P Mogensen.   

Abstract

OBJECTIVE: To investigate the long-term predictive value of urodynamics for the outcome of patients undergoing prostatic surgery for lower urinary tract symptoms (LUTS) suggestive of bladder outlet obstruction (BOO) and to determine the long-term effectiveness on symptoms, maximum flow rate and the rate of re-operation. PATIENTS AND METHODS: Of 139 elderly men who had undergone prostatic surgery, selected without reference to urodynamic assessment but having extensive (blinded) urodynamic testing included in their evaluation, 79 were followed for 8 years using a history, symptom score analysis, uroflowmetry and review of their records.
RESULTS: Comparing the results in groups of men with a pre-operative maximum flow rate < or > or = 15 mL/s, there was a similar difference in the rate of success to that noted 6 months post-operatively. Similar results were obtained when comparing those with BOO or a normal bladder outlet function. However, although the tendency was clear it was not statistically significant because of the small sample size (type-2 error). There was a significant reduction in all symptom scores from those assessed pre-operatively and during the 8 years (P < 0.001). The median pre-operative maximum flow rate was 8.5 mL/s, compared with 12.5 mL/s after 8 years (P < 0.001). Of the 79 patients, 14 (18%) had 28 re-operations during the 8-year follow-up, 12 being repeat resections of the prostate, giving a repeat resection rate of 1.8% per year and a success rate of 71%. During the 8 years, 82% of the patients had an unchanged overall evaluation of the post-operative outcome. In general, those having an unsatisfactory outcome were slightly younger than the whole group.
CONCLUSION: Uroflowmetry and pressure-flow studies can predict to some degree the long-term result after prostatic surgery. There was a durable effect on symptom scores and maximum flow rates after the operation. The annual rate of repeat resection (1.8%) was relatively low.

Entities:  

Mesh:

Year:  1996        PMID: 8813916     DOI: 10.1046/j.1464-410x.1996.11012.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  6 in total

1.  [Guidelines for German urologists on diagnosis of benign prostate syndrome].

Authors:  R Berges; K Dreikorn; K Höfner; U Jonas; K U Laval; S Madersbacher; M C Michel; R Muschter; M Oelke; L Pientka; C Tschuschke; U Tunn; K Schalkhäuser; B Göckel-Beining; A Heidenreich; H Rübben; K Schalkhäuser; W Thon; J Thüroff; W Weidner
Journal:  Urologe A       Date:  2003-03-12       Impact factor: 0.639

2.  [S2e guideline of the German urologists: Instrumental treatment of benign prostatic hyperplasia].

Authors:  T Bschleipfer; T Bach; R Berges; K Dreikorn; C Gratzke; S Madersbacher; M-S Michel; R Muschter; M Oelke; O Reich; C Tschuschke; K Höfner
Journal:  Urologe A       Date:  2016-02       Impact factor: 0.639

Review 3.  The Use of Urodynamics Assessment Before the Surgical Treatment of BPH.

Authors:  Ahmed El-Zawahry; Shaheen Alanee; Angela Malan-Elzawahry
Journal:  Curr Urol Rep       Date:  2016-10       Impact factor: 3.092

Review 4.  Urodynamics: what to do and when is it clinically necessary?

Authors:  Matthew P Rutman; Jerry G Blaivas
Journal:  Curr Urol Rep       Date:  2007-07       Impact factor: 3.092

5.  Salvage Holmium laser enucleation of prostate to treat residual benign prostatic hyperplasia.

Authors:  Jin Kyu Oh; Jungbum Bae; Chang Wook Jeong; Jae-Seung Paick; Seung-June Oh
Journal:  Can Urol Assoc J       Date:  2014-03       Impact factor: 1.862

6.  The relation between the storage symptoms before and after transurethral resection of the prostate, analysis of the risk factors and the prevention of the symptoms with solifenacin.

Authors:  Timucin Sipal; Hakan Akdere
Journal:  Int Braz J Urol       Date:  2020 Jul-Aug       Impact factor: 1.541

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.